White Paper: Physician Access and Appointment Requirements

Published by SK&A, A Cegedim Company

Nearly half of U.S. physicians say they require or prefer appointments to be made by pharmaceutical sales reps prior to one-on-one meetings or details, while about 23 percent of doctors refuse to see reps at any time at any of their practice locations, according to this updated survey by SK&A, A Cegedim Company. Use this report to identify see and no-see prescribers, improve engagement tactics, honor preferences and connect more successfully.

Click Here to Download the White Paper

HOT TOPICS
Label Changes
Over-the-counter medication labels contain a seemingly infinite amount of microscopic words that most people struggle to understand. One solution—well, a picture is worth a thousand words. In a new study, researchers at Northwestern University wanted to understand what is missing in consumer education that is causing the constant (and often accidental) misuse of acetaminophen, a well-known pain reliever, which, when misapplied, can lead to acute liver failure and even death. ..…
Pharmacist Survey
When consumers are seeking advice on over-the-counter (OTC) products, it turns out the pharmacist knows best. Pharmacists believe that 81% of consumers purchase an OTC product based on their recommendation, according to the 2010 Pharmacy Today Over-the-Counter Product Survey. The annual survey conducted by the American Pharmacists Association also revealed that 92% of pharmacists will actually take consumers to the OTC section when assisting them and that the average patient consult takes about three minutes.
DOUBLE ANTIDEPRESSANTS
When you double down in blackjack, you either lose big or win big, but when you double down on antidepressants, you only have the potential to lose. A study by researchers at UT Southwestern Medical Center found that taking two medications for depression does not hasten recovery times. In fact, the only things likely to increase are cost and side effects.
The Combining Medication to Enhance Depression Outcomes, or CO-MED, study was conducted at 15 sites across the country with a total of 665 patients ages 18 to 75 with major depressive disorder. There were three treatment groups: one received escitalopram (a selective serotonin reuptake inhibitor, or SSRI) and a placebo; the second also received escitalopram along with bupropion (a non-tricyclic antidepressant); and the third took venlafaxine (a tetracyclic antide- pressant) and mirtazapine (a serotonin norepinephrine reuptake inhibitor)..…
FDA UPDATE
FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) sent a warning letter to Shire Pharmaceuticals after a complaint was submitted to the DDMAC Bad Ad Program about a magnet for Vyvanse (lisdexamfetamine dimesylate) Capsules CII; the FDA and the Federal Trade Commission (FTC) announced a joint effort to remove products from the market that make unproven claims to treat, cure, and prevent sexually transmitted diseases (STDs); The FDA cleared the first test for Staphylococcus aureus (S. aureus) infections that is able to quickly identify whether the bacteria are methicillin resistant (MRSA)
or methicillin susceptible (MSSA); and more…

To Access ALL of PM360's Experts on Call Click Here!
FEATURES
PM360 COVER STORY: The Marketing Plan–Critical Success Factors
By Mick Kolassa and Brenda Cole
The fundamentals of marketing-plan success haven’t changed: Systematic execution, timely development, and sticking to the basics. Here’s how to make it work.
Driving "High Influence" Physicians Through the Product Adoption Process
By Martin Akel
Results of "How Physicians Learn and Make Decisions about Drug Therapy," a survey of 1,480 practicing physicians in 14 specialties.
Think Tank: Adherence Strategies and Solutions Our expert panel shares unexpected patient behaviors, surprisingly effective adherence-building tools, effectiveness measures, and success stories. With Shera Gruen, Jean LaLonde, Andrew Peterson, Vernon Schabert, and Richard G. Stefanacci.
Brand Personality: More Important than Ever
By Ed Shankman
In today’s cultural and regulatory environment, brand personality is increasingly vital to overall marketing success. Here is a disciplined approach to developing a personality that will differentiate your brand.
From Products to Solutions: Shifting the Marketing Emphasis to the Patient
By Bob Previdi
Changing business models and empowered patients are challenging marketers. Incentives and advance customer relationship management offer a potent mix for reaching the new patient.





THE GREATEST CREATORS 2011
Think Different
By Andrew Matthius
The Seven Deadly Sins of Healthcare Marketers
How erring marketers stymie creative success.
By Paul Harrington, SVP/Creative Director, Palio
The 36 Deadly Habits of Dysfunctional Creative Programs
A collection of crowdsourced responses on the behaviors that can kill creativity.
The Readers of PM360
PM360's Greatest Creators Showcase
Top healthcare agencies describe the obstacles they had to overcome to make their campaigns successful
Forging an International Brand: One World. One Campaign.
How to decide if a single global campaign is right for your brand.
By Christian Bauman, Managing Director/Chief Creative Officer, H4B Chelsea, Havas Worldwide Health
Directory of Creative Agencies
IN THIS ISSUE
Publisher’s Taking the Pulse
Guest Commentary Disruption in Data Mining? Ken Ribotsky and Ken Kramer
Common Sense Choose Your Perspective Bud Bilanich
Compliance Center Plan Now for Sunshine Implementation Bill Buzzeo
Industry Briefs Google Pays Online Rx Fine, and more
E-Source Warning: Failing to Tailor Your Message to the Prescriber Is Hazardous to Your Brand's Health Rob Likoff and Jim McDonough
DTC 360 The Death of DTC Has Been Greatly Exaggerated Richard Meyer
Healthcare Highlights Questions on combining antidepressants, FDA Updates, and more
Life Style Summer Stages: Live Theater around the USA
Market WatchProstrate Cancer Jane Quigley and Scott Hulnick
Market Drill-Down A New Plug for the Leaky Bucket Paula Fullman
PR 360 The New Age of Communications Convergence–Pattern Recognition Gil Bashe
Cutting Edge Gadgets and gear for today's on-the-go professional
The Scene BiggerFuture, Rwanda Dave Ormesher
Movers & Shakers Career changes in the industry
Calendar A quick reference list of upcoming industry events
Weird Science A Medical Device Mystery!

2011 Editorial Calendar Now Available!

Click Here to Download


Site ©2008-2011 AMS Group LLC.

blog comments powered by Disqus